ATRA vs MCO · rev $128.9M vs P/E 33, rev $7.72B
Atara Biotherapeutics Inc (ATRA) versus Moodys Corporation (MCO) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported MCO revenue for 2025-12-31 was $7.72B. Net income was $2.46B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
ATRA currently screens at market cap $87.1M. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Not investment advice. Open the ATRA and MCO stock pages for the full models.
Not investment advice.